articleNew England Journal of MedicineJun 9, 2004BRONZE OA

Quantification of Plasma Epstein–Barr Virus DNA in Patients with Advanced Nasopharyngeal Carcinoma

Taichung Veterans General Hospital · National Cheng Kung University Hospital · +2 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

Background

We investigated the clinical significance of plasma concentrations of Epstein-Barr virus (EBV) DNA in patients with advanced nasopharyngeal carcinoma.

Methods

Ninety-nine patients with biopsy-proven stage III or IV nasopharyngeal carcinoma and no evidence of metastasis (M0) received 10 weekly chemotherapy treatments followed by radiotherapy. Plasma samples from the patients were subjected to a real-time quantitative polymerase-chain-reaction assay. EBV genotypes of paired samples from plasma and primary tumor were compared.

Citation impact

921
total citations
FWCI
20.64
Percentile
100%
References
32
Citations per year

Authors

7

Topics & keywords

Keywords
  • Nasopharyngeal carcinoma
  • Medicine
  • Virus
  • Gastroenterology
  • Internal medicine
  • Radiation therapy
  • Liter
  • Stage (stratigraphy)
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.